NewGenIvf Group Ltd
No SEC Form 4 filings for $NIVF in the last 30 days.
See all $NIVF insider activity →NewGen IVF (NIVF) rose 25% after a $1.25M share offering. SeaStar Medical (ICU) gained 23% on regulatory updates. Atara Biotherapeutics (ATRA) climbed 11% with a BLA resubmission. Indaptus Therapeutics (INDP) increased 9% without specific news. All stocks traded higher on Friday.
NewGenIvf Group (NASDAQ:NIVF) shares rose 28.51% to $0.13 in after-hours trading after closing a public offering, raising $1.25M before fees. The offering included 17.85M Class A shares and pre-funded warrants at $0.07 per share and $0.06999 per warrant. The company's market cap is approximately $209,870, with a 52-week range of $1.539 to $0.06.
U.S. stocks fell Thursday, with the Dow Jones dropping 200 points. Micron (MU) reported Q4 revenue of $54.23B, beating estimates. Nexalin (NXL) and Stablecoin (SDEV) shares surged, while Corteva (CTVA) and NewGenIvf (NIVF) shares declined. Oil and gold prices rose, while European and Asian markets closed mixed.
Over the past 7 days, AlphAI's AI scored 6 news stories mentioning NIVF (NewGenIvf Group Ltd). Coverage has skewed bearish: 2 bullish, 1 neutral, and 3 bearish.
Recent NIVF coverage spans corporate actions, financial news and earnings.
Capital raise provides cash for debt restructuring and growth initiatives.
The fresh capital raise is expected to support operations and may sustain short‑term buying pressure.
Offering dilution and low price pressure the stock.
The modest raise adds cash but increases share count, likely causing slight downward pressure on the stock.
Equity raise dilutes existing shareholders.
AlphAI scores every news story that mentions NIVF with an AI model for sentiment and relevance, and aggregates insider trades from NewGenIvf Group Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.
NewGen IVF (NIVF) rose 25% after a $1.25M share offering. SeaStar Medical (ICU) gained 23% on regulatory updates. Atara Biotherapeutics (ATRA) climbed 11% with a BLA resubmission. Indaptus Therapeutics (INDP) increased 9% without specific news. All stocks traded higher on Friday.
2 min readNewGenIvf Group (NASDAQ:NIVF) shares rose 28.51% to $0.13 in after-hours trading after closing a public offering, raising $1.25M before fees. The offering included 17.85M Class A shares and pre-funded warrants at $0.07 per share and $0.06999 per warrant. The company's market cap is approximately $209,870, with a 52-week range of $1.539 to $0.06.
1 min readU.S. stocks fell Thursday, with the Dow Jones dropping 200 points. Micron (MU) reported Q4 revenue of $54.23B, beating estimates. Nexalin (NXL) and Stablecoin (SDEV) shares surged, while Corteva (CTVA) and NewGenIvf (NIVF) shares declined. Oil and gold prices rose, while European and Asian markets closed mixed.
3 min readNewGenIvf Group (NIVF) closed a $1.25 million public offering, issuing 17.86 million Class A shares and pre-funded warrants at $0.07 and $0.07 each. Proceeds will fund investments, debt restructuring, and working capital. Aegis Capital Corp. acted as placement agent.
1 min readDow Jones fell 100 points, while Carnival (CCL) reported Q3 earnings of $1.43 per share, beating estimates. NASDAQ and S&P 500 also saw mixed trading. BIO-Key (BKYI) and SoundThinking (SSTI) shares surged on strategic news. NewGenIvf (NIVF) and Triller (ILLR) shares dropped significantly.
2 min readBiotech stocks SLXN and SMMT rose premarket. SLXN gained on positive preclinical data, while SMMT jumped after a $2B equity investment from AZN. NIVF and QURE declined.
1 min readOn September 2, 2026, insiders made notable stock purchases. AURA MINERALS INC. ($AUGO) insider Bruno Sousa Mauad bought 126,000 shares for $11.26M. NEWGENIVF GROUP LTD ($NIVF) insider Cheung Kong Yiu purchased 2.5M shares for $2.5M. EMPERY DIGITAL INC. ($EMPD) insider Empery Asset Management, LP bought 500,000 shares for $1.79M. VISTRA CORP. ($VST) CEO James A. Burke acquired 4,465 shares for $603,891. LIBERTY LATIN AMERICA LTD. ($LILA) insider John C. Malone bought 69,454 shares for $590,310.
1 min readCheung Kong Yiu purchased 3,722,223 shares of NewGenIvf Group Ltd (NIVF) at an average of $1.12 ($1.00–$1.50, $4.16M total) across 4 trades over 2026-05-28 to 2026-07-27.
1 min readNewGenIvf Group (NIVF) said it agreed to buy an additional 3% equity stake in K25.ai for $250 million, raising its total ownership to 13%. The deal is expected to issue about 2.5 million Class A ordinary shares. NIVF was indicated at $1.07 in pre-market, down 4.46% on Nasdaq.
2 min readNewGenIVF (NIVF) said it issued 3,666,667 new shares under a strategic share purchase agreement to acquire a 10% equity interest in K25.ai. The company reported 10,073,535 total shares outstanding and a US$7.63 million market cap as of June 18, 2026, below its US$25.98 million net asset value (Dec. 31, 2025). It also cited a US$10 million investment in K25.ai to support its AI-focused strategy and Nasdaq MVLS compliance.
3 min read
